Marshall Wace North America’s Elanco Animal Health ELAN Stock Holding History

Marshall Wace North America’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$955K	Sell	29,944 -1,239,373	-98%	-$41.6M	﹤0.01%	941
2021 Q2	$44M	Buy	1,269,317 +291,450	+30%	+$9.61M	0.18%	119
2021 Q1	$28.8M	Sell	977,867 -20,191	-2%	-$621K	0.12%	197
2020 Q4	$30.6M	Buy	998,058 +477,649	+92%	+$14.6M	0.14%	179
2020 Q3	$14.5M	Buy	+520,409	New	+$13.2M	0.09%	228
2020 Q1	–	Sell	-1,695	Closed	-$50K	–	1323
2019 Q4	$50K	Sell	1,695 -43,916	-96%	-$1.19M	﹤0.01%	1154
2019 Q3	$1.21M	Buy	+45,611	New	+$1.37M	0.01%	650
2019 Q1	–	Sell	-6,810	Closed	-$215K	–	1647
2018 Q4	$215K	Sell	6,810 -136,209	-95%	-$4.46M	﹤0.01%	945
2018 Q3	$4.99M	Buy	+143,019	New	+$5.03M	0.03%	318

Other funds holding ELAN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Marshall Wace North America's ELAN Position: Q3 2021 in Review

Marshall Wace North America reduced its Elanco Animal Health (ELAN) stake by 98% in Q3 2021, selling an estimated $41.6M and leaving 29,944 shares worth $955K. The position accounts for ﹤0.01% of the portfolio, ranked #941.

Marshall Wace North America first reported a position in ELAN in Q3 2018 and has held it in 9 quarters since. The position peaked at $44M in Q2 2021. 453 funds tracked by Wall St. Rank hold ELAN as of Q3 2021.

Marshall Wace North America held 29,944 shares of Elanco Animal Health worth $955K as of Q3 2021.
Marshall Wace North America sold 1,239,373 Elanco Animal Health shares in Q3 2021, an estimated $41.6M.
Elanco Animal Health made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #941 holding.
Marshall Wace North America first reported a position in Elanco Animal Health in Q3 2018 and has held it in 9 quarters since.
Marshall Wace North America's Elanco Animal Health position peaked at $44M in Q2 2021.
453 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.